The university has renamed its genomics center, specializing in the gut microbiome, the Edison Family Center for Genome Sciences and Systems Biology.
The funds will be used to develop personalized treatments through collaborations within the Boston community, speed up clinical trials, and remove data bottlenecks.
The Harris Center for Precision Wellness will leverage emerging technologies in genomics, digital health, and data science.
The gift is from a group of more than 20 philanthropists and will be used to develop a rapid diagnostic test for drug-resistant TB.
The gift from the Hersch Foundation also will be used to create the Julie K. Hersch Chair in depression research and clinical care.
With funding from CurePSP, the collaborators will investigate the genetic causes of the disease, which affects a patients' speech, mobility, balance, and other abilities.
Parlaying expertise in genetics, pathology, radiology, immunology, and gastroenterology, the center will focus on personalized medicine for Crohn's disease.
Under a pilot run, CytoVale, a developer of technologies for high-throughput single-cell analysis, has received funding and been assigned a mentor from BD.
Among the uses of the funding, UW will conduct exome sequencing to determine a patient's risk for developing the disease.
The gift will go toward the creation of theBartBarlogieCenterfor Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.